U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07674550) titled 'Biological Collection on Emerging Infectious Diseases and Their Treatments' on June 09.
Brief Summary: Unprecedented changes in human-environment interactions and increasing disruptions to ecosystems and the climate have contributed to the emergence of infectious diseases (Emerging Infectious Diseases, EIDs). Advances in the treatment of cancers, malignant haematological disorders and immune-mediated inflammatory diseases are also contributing to the creation of new infectious risks among immunocompromised patient populations.
The COVID-19 pandemic has shown that structuring research prior to any outbreak is essential for the rapid...